The information highlighted (if any) are the most recent updates for this brand.
Full Prescribing Info
Indications/Uses
SPIOLTO RESPIMAT is indicated for the second line treatment in patients with COPD when tiotropium or olodaterol alone does not provide adequate responses to reduce airflow obstruction, to improve quality of life and to reduce associated dyspnoea.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign Out
